tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Viavi price target raised to $17 from $12 at UBS

UBS raised the firm’s price target on Viavi (VIAV) to $17 from $12 and keeps a Neutral rating on the shares. AI and data center demand drove a strong quarter and guidance, the analyst tells investors in a research note.

TipRanks Cyber Monday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1